| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.5 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.5 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.031 | 0.5 |